Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

Alexander M. Menzies(The University of Sydney), Douglas B. Johnson(Vanderbilt University Medical Center), Sangeetha Ramanujam(The University of Sydney), Victoria Atkinson(Greenslopes Private Hospital), Annie Wong(Peter MacCallum Cancer Centre), John Park, Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Alexander N. Shoushtari(Memorial Sloan Kettering Cancer Center), Katy K. Tsai(University of California, San Francisco), Zeynep Eroglu(Moffitt Cancer Center), Oliver Klein(Olivia Newton-John Cancer Wellness & Research Centre), Jessica C. Hassel(Heidelberg University), Jeffrey A. Sosman(Vanderbilt University Medical Center), Alexander Guminski(The University of Sydney), Ryan J. Sullivan(Massachusetts General Hospital), Antoni Ribas(University of California, Los Angeles), Matteo S. Carlino(The University of Sydney), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Shahneen Sandhu(Peter MacCallum Cancer Centre), Georgina V. Long(The University of Sydney)
Annals of Oncology
September 30, 2016
Cited by 820Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis